GJD2 and Huntington disease: Reduction of Cx36 expression in Huntington’s disease (Petrasch-Parwez et al., 2004) and global reduction of Cx43, Cx32, and Cx47 in Balo’s disease (Masaki et al., 2012) are prominent features in these disorders.